Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2020-2026

Global Prostate Specific Antigen (PSA) Biomarker Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
1.4 Market Analysis by Type
1.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Blood
1.4.3 Semen
1.4.4 Urine
1.5 Market by Application
1.5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Drug Discovery
1.5.4 Personalized Medicine
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Prostate Specific Antigen (PSA) Biomarker Industry Impact
1.6.1 How the Covid-19 is Affecting the Prostate Specific Antigen (PSA) Biomarker Industry
1.6.1.1 Prostate Specific Antigen (PSA) Biomarker Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Prostate Specific Antigen (PSA) Biomarker Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Prostate Specific Antigen (PSA) Biomarker Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Prostate Specific Antigen (PSA) Biomarker Market Perspective (2015-2026)
2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Regions
2.2.1 Prostate Specific Antigen (PSA) Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Prostate Specific Antigen (PSA) Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Specific Antigen (PSA) Biomarker Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Market Size
3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2015-2020)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2019
3.3 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
3.4 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
3.5 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2021-2026)
5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application (2015-2026)
5.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
6.2 Prostate Specific Antigen (PSA) Biomarker Key Players in North America (2019-2020)
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
7.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Europe (2019-2020)
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
8 China
8.1 China Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
8.2 Prostate Specific Antigen (PSA) Biomarker Key Players in China (2019-2020)
8.3 China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
8.4 China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
9.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Japan (2019-2020)
9.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
9.4 Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
10.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
11 India
11.1 India Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
11.2 Prostate Specific Antigen (PSA) Biomarker Key Players in India (2019-2020)
11.3 India Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
11.4 India Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size (2015-2020)
12.2 Prostate Specific Antigen (PSA) Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
13.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Siemens Healthcare
13.2.1 Siemens Healthcare Company Details
13.2.2 Siemens Healthcare Business Overview and Its Total Revenue
13.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
13.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.2.5 Siemens Healthcare Recent Development
13.3 DiaSorin
13.3.1 DiaSorin Company Details
13.3.2 DiaSorin Business Overview and Its Total Revenue
13.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
13.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.3.5 DiaSorin Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
13.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Tosoh Bioscience
13.5.1 Tosoh Bioscience Company Details
13.5.2 Tosoh Bioscience Business Overview and Its Total Revenue
13.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
13.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.5.5 Tosoh Bioscience Recent Development
13.6 Fujirebio
13.6.1 Fujirebio Company Details
13.6.2 Fujirebio Business Overview and Its Total Revenue
13.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
13.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.6.5 Fujirebio Recent Development
13.7 BodiTech
13.7.1 BodiTech Company Details
13.7.2 BodiTech Business Overview and Its Total Revenue
13.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
13.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.7.5 BodiTech Recent Development
13.8 GE Healthcare
13.8.1 GE Healthcare Company Details
13.8.2 GE Healthcare Business Overview and Its Total Revenue
13.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
13.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.8.5 GE Healthcare Recent Development
13.9 Endocare
13.9.1 Endocare Company Details
13.9.2 Endocare Business Overview and Its Total Revenue
13.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
13.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.9.5 Endocare Recent Development
13.10 Quest Diagnostics
13.10.1 Quest Diagnostics Company Details
13.10.2 Quest Diagnostics Business Overview and Its Total Revenue
13.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
13.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
13.10.5 Quest Diagnostics Recent Development
13.11 Bio-Rad Laboratories
10.11.1 Bio-Rad Laboratories Company Details
10.11.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
10.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
10.11.5 Bio-Rad Laboratories Recent Development
13.12 QIAGEN
10.12.1 QIAGEN Company Details
10.12.2 QIAGEN Business Overview and Its Total Revenue
10.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
10.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
10.12.5 QIAGEN Recent Development
13.13 Myriad RBM
10.13.1 Myriad RBM Company Details
10.13.2 Myriad RBM Business Overview and Its Total Revenue
10.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
10.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
10.13.5 Myriad RBM Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Prostate Specific Antigen (PSA) Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
Table 3. Ranking of Global Top Prostate Specific Antigen (PSA) Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Blood
Table 6. Key Players of Semen
Table 7. Key Players of Urine
Table 8. COVID-19 Impact Global Market: (Four Prostate Specific Antigen (PSA) Biomarker Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Prostate Specific Antigen (PSA) Biomarker Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Prostate Specific Antigen (PSA) Biomarker Players to Combat Covid-19 Impact
Table 13. Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2015-2020)
Table 17. Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Prostate Specific Antigen (PSA) Biomarker Market Growth Strategy
Table 23. Main Points Interviewed from Key Prostate Specific Antigen (PSA) Biomarker Players
Table 24. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Players (2015-2020) (Million US$)
Table 25. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players (2015-2020)
Table 26. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2019)
Table 27. Global Prostate Specific Antigen (PSA) Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
Table 30. Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 33. Global Prostate Specific Antigen (PSA) Biomarker Market Size Share by Type (2015-2020)
Table 34. Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Type (2021-2026)
Table 35. Global Prostate Specific Antigen (PSA) Biomarker Market Size Share by Application (2015-2020)
Table 36. Global Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 37. Global Prostate Specific Antigen (PSA) Biomarker Market Size Share by Application (2021-2026)
Table 38. North America Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 40. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 41. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 42. North America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 43. North America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 44. Europe Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 46. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 48. Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 50. China Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 51. China Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 52. China Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 53. China Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 54. China Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 55. China Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 56. Japan Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 58. Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 60. Japan Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 64. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 66. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 68. India Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 69. India Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 70. India Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 71. India Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 72. India Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 73. India Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Prostate Specific Antigen (PSA) Biomarker Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Prostate Specific Antigen (PSA) Biomarker Market Share (2019-2020)
Table 76. Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Prostate Specific Antigen (PSA) Biomarker Market Share by Type (2015-2020)
Table 78. Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Prostate Specific Antigen (PSA) Biomarker Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Siemens Healthcare Company Details
Table 86. Siemens Healthcare Business Overview
Table 87. Siemens Healthcare Product
Table 88. Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 89. Siemens Healthcare Recent Development
Table 90. DiaSorin Company Details
Table 91. DiaSorin Business Overview
Table 92. DiaSorin Product
Table 93. DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 94. DiaSorin Recent Development
Table 95. Roche Company Details
Table 96. Roche Business Overview
Table 97. Roche Product
Table 98. Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 99. Roche Recent Development
Table 100. Tosoh Bioscience Company Details
Table 101. Tosoh Bioscience Business Overview
Table 102. Tosoh Bioscience Product
Table 103. Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 104. Tosoh Bioscience Recent Development
Table 105. Fujirebio Company Details
Table 106. Fujirebio Business Overview
Table 107. Fujirebio Product
Table 108. Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 109. Fujirebio Recent Development
Table 110. BodiTech Company Details
Table 111. BodiTech Business Overview
Table 112. BodiTech Product
Table 113. BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 114. BodiTech Recent Development
Table 115. GE Healthcare Business Overview
Table 116. GE Healthcare Product
Table 117. GE Healthcare Company Details
Table 118. GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 119. GE Healthcare Recent Development
Table 120. Endocare Company Details
Table 121. Endocare Business Overview
Table 122. Endocare Product
Table 123. Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 124. Endocare Recent Development
Table 125. Quest Diagnostics Company Details
Table 126. Quest Diagnostics Business Overview
Table 127. Quest Diagnostics Product
Table 128. Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 129. Quest Diagnostics Recent Development
Table 130. Bio-Rad Laboratories Company Details
Table 131. Bio-Rad Laboratories Business Overview
Table 132. Bio-Rad Laboratories Product
Table 133. Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 134. Bio-Rad Laboratories Recent Development
Table 135. QIAGEN Company Details
Table 136. QIAGEN Business Overview
Table 137. QIAGEN Product
Table 138. QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 139. QIAGEN Recent Development
Table 140. Myriad RBM Company Details
Table 141. Myriad RBM Business Overview
Table 142. Myriad RBM Product
Table 143. Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020) (Million US$)
Table 144. Myriad RBM Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Blood Features
Figure 3. Semen Features
Figure 4. Urine Features
Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Application: 2020 VS 2026
Figure 6. Diagnostics Case Studies
Figure 7. Drug Discovery Case Studies
Figure 8. Personalized Medicine Case Studies
Figure 9. Others Case Studies
Figure 10. Prostate Specific Antigen (PSA) Biomarker Report Years Considered
Figure 11. Global Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions: 2020 VS 2026
Figure 13. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Prostate Specific Antigen (PSA) Biomarker Market Share by Players in 2019
Figure 16. Global Top Prostate Specific Antigen (PSA) Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Specific Antigen (PSA) Biomarker as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2019
Figure 18. North America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Prostate Specific Antigen (PSA) Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Abbott Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 27. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Siemens Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 29. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. DiaSorin Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 31. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Roche Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 33. Tosoh Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Tosoh Bioscience Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 35. Fujirebio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Fujirebio Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 37. BodiTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. BodiTech Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 39. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GE Healthcare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 41. Endocare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Endocare Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 43. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Quest Diagnostics Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 45. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Bio-Rad Laboratories Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 47. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. QIAGEN Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 49. Myriad RBM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Myriad RBM Revenue Growth Rate in Prostate Specific Antigen (PSA) Biomarker Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs